Glicaramide
Glicaramide (SQ-65993) is an orally bioavailable anti-diabetic medication.[1] It has a similar potency as glibenclamide (glyburide) in the class of medication known as sulfonylureas. Its structure is similar since it has a cyclic acyl group which replaces the latter's 2-methoxy-5-chlorobenzyl.[2] Same as glibenclamide, it is classified as a second-generation sulfonylurea. It may have more pronounced extra-pancreatic effects than glibenclamide or tolbutamide.[3]
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C30H42N6O5S |
Molar mass | 598.7567 g/mol g·mol−1 |
See also
References
- Hoehn, H.; Polacek, I.; Schulze, E. (1973). "Potential antidiabetic agents. Pyrazolo[3,4-b]pyridines". Journal of Medicinal Chemistry. 16 (12): 1340–1346. doi:10.1021/jm00270a006. PMID 4358224.
- Progress in Medicinal Chemistry, Volume 18 (v. 18) (Hardcover). Elsevier Science. 1981. ISBN 0-444-80345-9.
- West, G.B. (Jan 1, 1981). Ellis, GP (ed.). Progress in medicinal chemistry. Amsterdam: Elsevier. p. 202. ISBN 9780444803450.
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.